Milestone Pharmaceuticals Inc (MIST)
$1.47
Performance
- $1.47$1.51$1.47
0.0%
Downside
Day's Volatility :2.62%
Upside
2.62%
- $1.12$3.52$1.47
23.81%
Downside
52 Weeks Volatility :68.18%
Upside
58.24%
Returns
| Period | Milestone Pharmaceuticals Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -2.65% | 0.0% |
6 Months | -13.27% | 0.0% |
1 Year | -51.16% | 0.0% |
3 Years | -74.87% | -20.3% |
Highlights
Market Capitalization | 78.3M |
Book Value | $0.48 |
Earnings Per Share (EPS) | -1.01 |
Wall Street Target Price | 10.25 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -33.09% |
Return On Equity TTM | -133.75% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -100.0% |
Gross Profit TTM | 5.0M |
EBITDA | -49.2M |
Diluted Eps TTM | -1.01 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.63 |
EPS Estimate Next Year | -0.86 |
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Next Quarter | -0.19 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 597.28%
Technicals Summary
Sell
Neutral
Buy
Milestone Pharmaceuticals Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Milestone Pharmaceuticals Inc | 1.38% | -13.27% | -51.16% | -74.87% | -91.63% |
 Regeneron Pharmaceuticals, Inc. | -12.48% | 8.55% | 19.49% | 82.88% | 232.15% |
 Novo Nordisk A/s | -13.09% | -6.28% | 18.91% | 138.88% | 358.83% |
 Alnylam Pharmaceuticals, Inc. | 6.38% | 83.19% | 66.02% | 36.22% | 252.82% |
 Vertex Pharmaceuticals Incorporated | 0.3% | 18.97% | 30.36% | 165.15% | 176.17% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc | NA | NA | NA | -0.63 | -1.34 | -0.33 | NA | 0.48 |
Regeneron Pharmaceuticals, Inc. | 26.81 | 26.81 | 1.38 | 45.04 | 0.17 | 0.08 | NA | 261.41 |
Novo Nordisk A/s | 39.53 | 39.53 | 1.79 | 3.39 | 0.89 | 0.23 | 0.01 | 25.24 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.38 | -15.01 | 0.02 | NA | -0.02 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 0.58 | 0.33 | -0.03 | 0.13 | NA | 57.26 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Milestone Pharmaceuticals Inc | Buy | $78.3M | -91.63% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $111.6B | 232.15% | 26.81 | 32.04% |
Novo Nordisk A/s | Buy | $519.8B | 358.83% | 39.53 | 34.84% |
Alnylam Pharmaceuticals, Inc. | Buy | $35.8B | 252.82% | NA | -3.11% |
Vertex Pharmaceuticals Incorporated | Buy | $122.9B | 176.17% | 32.84 | -4.74% |
Insights on Milestone Pharmaceuticals Inc
Decreasing Revenue
Revenue is down for the last 4 quarters, 3.5M → -868.00K (in $), with an average decrease of 86.1% per quarter
Increasing Net Profit
Netprofit is up for the last 5 quarters, -16.04M → -9.36M (in $), with an average increase of 14.8% per quarter
Vs ALNY
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.0% return, outperforming this stock by 117.2%
Vs VRTX
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 36.2% return, outperforming this stock by 111.1%
Institutional Holdings
BlackRock Inc
9.33%Nantahala Capital Management, LLC
6.57%RTW INVESTMENTS, LLC
6.11%Millennium Management LLC
5.16%Alta Fundamental Advisers LLC
4.99%Lion Point Capital, LP
4.39%
Company Information
milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.
Organization | Milestone Pharmaceuticals Inc |
Employees | 47 |
CEO | Mr. Joseph G. Oliveto M.B.A. |
Industry | Pharmaceuticals: Major |
Discover More
Centuri Holdings Inc.
$1.47
-2.0%
Lions Gate Entertainment Corp. Class B
$1.47
-2.0%
E. W. Scripps Company, Class A Shares
$1.47
-2.0%
Australian Oilseeds Holdings
$1.47
-2.0%
Defe Dly Tr 1.75x L Mstr Etf
$1.47
-2.0%
Diversified Healthcare Trust
$1.47
-2.0%
Hartford Multifactor Small C
$1.47
-2.0%
Proshares Decline Of The Ret
$1.47
-2.0%
United Homes Group Inc
$1.47
-2.0%